Singapore life sciences firm Esco to seek up to $100m for spin-off fund

Singapore life sciences firm Esco to seek up to $100m for spin-off fund

Xiang Qian (XQ) Lin, CEO of Esco Lifesciences Group

AT Medical UABEsco GroupEsco MicroLin XiangqianSingaporeVCventure capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.